Valeant Pharmaceuticals
International, Inc. VRX announced that Valeant's Medicis
division, a leader in facial injectables and professional skin care, has
formed a collaboration with Mentor Worldwide LLC, the U.S. market leader in
breast aesthetics, to enter certain of their non-reimbursed products into a
combined physician loyalty program. The new program, called the M^2VP
(Medicis-Mentor Valued Partner) program, extends the offerings of Medicis'
recently-launched MVP program to include the MENTOR^® line of breast implant
products for a five-year term and is for the U.S., subject to any geographical
expansion that may be agreed upon by the parties.
The M^2VP program offers numerous incentives that reward utilization of
various products across the Mentor and Medicis portfolios. Unlike other
programs in the space, the M^2VP program allows participating members to not
only earn points that establish status within the program, but to redeem them
for items such as product purchases. In designing the program, Mentor and
Medicis sought to address many of the issues that customers felt existed with
other programs.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in